Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Lingdong Biotechnology (Lingdong Biotech) is a specialized life sciences company focused on single-cell sequencing and spatial multi-omics technologies. Founded in 2017, the company provides a comprehensive technology platform for high-throughput single-cell RNA sequencing, spatial transcriptomics, and integrated bioinformatics services to support drug discovery and clinical research. Lingdong Biotech operates as a key partner for pharmaceutical companies and academic institutions, offering end-to-end solutions from sample preparation to advanced data interpretation. Their expertise spans various therapeutic areas, including oncology, immunology, and neuroscience, where they help identify novel biomarkers and therapeutic targets through cellular heterogeneity analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ling Dong.